132 results
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:18pm
characterizing safety, tolerability and preliminary efficacy of SP-103 in acute LBP associated with muscle spasms. SP-103 was safe and well tolerated … efficacy and safety results. SP-103, if approved, could become the first FDA-approved lidocaine topical product for the treatment of chronic neck pain
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:15pm
characterizing safety, tolerability and preliminary efficacy of SP-103 in acute LBP associated with muscle spasms. SP-103 was safe and well tolerated … efficacy and safety results. SP-103, if approved, could become the first FDA-approved lidocaine topical product for the treatment of chronic neck pain
424B3
SCLX
Scilex Holding Company
25 Apr 24
Prospectus supplement
4:35pm
to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case
424B3
SCLX
Scilex Holding Company
25 Apr 24
Prospectus supplement
4:33pm
, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as would
8-K
EX-10.1
97qm4ws09h 1g
25 Apr 24
Scilex Holding Company Announces $15 Million Registered Direct Offering
4:30pm
424B5
tlf5f9fjs kgi
25 Apr 24
Prospectus supplement for primary offering
6:27am
424B3
rdpd0p1bjf0rw
2 Apr 24
Prospectus supplement
5:20pm
424B3
p2ysrx4a8x
2 Apr 24
Prospectus supplement
5:19pm
POS AM
dyijrti
27 Mar 24
Prospectus update (post-effective amendment)
5:30pm
POS AM
vj5wfa ri1x2h6f1
27 Mar 24
Prospectus update (post-effective amendment)
5:29pm
424B3
ckgxjb1emzjo1
5 Mar 24
Prospectus supplement
4:20pm
424B3
qup1f ya4oyxz
5 Mar 24
Prospectus supplement
4:17pm
424B3
zp1777y6vyhipyzwx
5 Mar 24
Prospectus supplement
4:16pm
424B3
cvn1 lcfv
5 Mar 24
Prospectus supplement
4:13pm
8-K
EX-1.1
24xcjk
5 Mar 24
Scilex Holding Company Announces $10 Million Bought Deal Offering
4:12pm
424B5
arbcp1kelpvz2wtmeze
4 Mar 24
Prospectus supplement for primary offering
4:02pm
424B5
4d84 th228j9u1o93
29 Feb 24
Prospectus supplement for primary offering
5:18pm
424B5
2h7 q5beubz4bqufyi1
11 Jan 24
Prospectus supplement for primary offering
4:53pm